CARETEXT Trademark

Trademark Overview

On Tuesday, June 26, 2012, a trademark application was filed for CARETEXT with the United States Patent and Trademark Office. The USPTO has given the CARETEXT trademark a serial number of 85661330. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 10, 2020. This trademark is owned by Ceretec, Inc.. The CARETEXT trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services, namely, disease management, medication compliance and adherence to medical regimens using personalized messaging and personal messaging
caretext

General Information

Serial Number85661330
Word MarkCARETEXT
Filing DateTuesday, June 26, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 10, 2020
Registration Number4445276
Registration DateTuesday, December 3, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical services, namely, disease management, medication compliance and adherence to medical regimens using personalized messaging and personal messaging
Pseudo MarkCARE TEXT

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 10, 2020
Primary Code044
First Use Anywhere DateFriday, November 30, 2012
First Use In Commerce DateFriday, November 30, 2012

Trademark Owner History

Party NameMONITORED THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDUBLIN, OH 43016
Party NameCeretec, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89134
Party NameCeretec, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLas Vegas, NV 89134

Trademark Events

Event DateEvent Description
Friday, July 10, 2020CANCELLED SEC. 8 (6-YR)
Saturday, May 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, May 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, May 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, May 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 3, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, August 8, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 3, 2013REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, October 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 30, 2013NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, October 29, 2013APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, October 29, 2013USE AMENDMENT ACCEPTED
Tuesday, October 29, 2013AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, October 29, 2013USE AMENDMENT FILED
Thursday, October 24, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 22, 2013ASSIGNED TO LIE
Friday, October 18, 2013TEAS AMENDMENT OF USE RECEIVED
Wednesday, May 1, 2013NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, May 1, 2013FINAL REFUSAL E-MAILED
Wednesday, May 1, 2013FINAL REFUSAL WRITTEN
Thursday, April 18, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 17, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 17, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 17, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 17, 2012NON-FINAL ACTION E-MAILED
Wednesday, October 17, 2012NON-FINAL ACTION WRITTEN
Tuesday, October 16, 2012ASSIGNED TO EXAMINER
Wednesday, July 4, 2012NOTICE OF PSEUDO MARK MAILED
Tuesday, July 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

caretext messaging medical regimens using personalized personal adherence compliance services namely